Oppenheimer & Co. Inc. Acquires New Holdings in SelectQuote, Inc. (NYSE:SLQT)

Oppenheimer & Co. Inc. bought a new position in SelectQuote, Inc. (NYSE:SLQT) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 12,526 shares of the company’s stock, valued at approximately $47,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Mason Investment Advisory Services Inc. grew its position in shares of SelectQuote by 33.3% during the 3rd quarter. Mason Investment Advisory Services Inc. now owns 20,000 shares of the company’s stock valued at $43,000 after acquiring an additional 5,000 shares during the period. Rhumbline Advisers lifted its position in SelectQuote by 2.6% during the fourth quarter. Rhumbline Advisers now owns 209,743 shares of the company’s stock valued at $780,000 after purchasing an additional 5,235 shares in the last quarter. Creative Planning grew its holdings in SelectQuote by 6.6% during the third quarter. Creative Planning now owns 100,019 shares of the company’s stock valued at $217,000 after purchasing an additional 6,150 shares during the period. SG Americas Securities LLC increased its position in SelectQuote by 10.5% in the fourth quarter. SG Americas Securities LLC now owns 91,508 shares of the company’s stock worth $340,000 after buying an additional 8,660 shares in the last quarter. Finally, State Street Corp raised its stake in shares of SelectQuote by 0.7% in the third quarter. State Street Corp now owns 2,894,067 shares of the company’s stock worth $6,280,000 after buying an additional 21,413 shares during the period. Hedge funds and other institutional investors own 34.59% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on SLQT shares. Noble Financial upgraded SelectQuote to a “strong-buy” rating in a research note on Wednesday, February 12th. Royal Bank of Canada restated a “sector perform” rating and set a $4.00 price objective on shares of SelectQuote in a research report on Friday, November 22nd.

SelectQuote Stock Down 1.5 %

NYSE SLQT opened at $3.55 on Monday. The stock has a 50 day moving average price of $4.45 and a 200-day moving average price of $3.30. SelectQuote, Inc. has a one year low of $1.48 and a one year high of $6.86. The company has a debt-to-equity ratio of 2.10, a quick ratio of 6.36 and a current ratio of 6.36. The company has a market capitalization of $610.25 million, a P/E ratio of -39.39 and a beta of 1.13.

SelectQuote (NYSE:SLQT) last released its quarterly earnings data on Monday, February 10th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.09 by $0.21. SelectQuote had a negative net margin of 0.95% and a negative return on equity of 4.38%. As a group, equities analysts predict that SelectQuote, Inc. will post -0.07 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Sarah Taylor Anderson sold 50,000 shares of the firm’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $5.44, for a total value of $272,000.00. Following the completion of the sale, the insider now owns 1,166 shares in the company, valued at approximately $6,343.04. This trade represents a 97.72 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.40% of the stock is currently owned by company insiders.

SelectQuote Company Profile

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.